About a million possible cases of atrial fibrillation, a known risk for stroke, go undetected in Japan. A local startup is introducing an innovative AI targeting this growing danger.
Founded in 2019, Cardio Intelligence develops a range of AI-powered solutions for continuous heart monitoring called SmartRobin AI.
The SmartRobin AI series is based on "explainable AI," which processes a huge...
The FDA announced the Apple Watch atrial fibrillation (AFib) tool is qualified for use in clinical trials through its Medical Device Development Tools (MDDT) program, thus enabling researchers to use it to detect arrhythmias or abnormal heart beat.
Apple's tool is the first digital health tool to be qualified under the MDDT program, a voluntary program aimed at evaluating devices for use in...
Late last month, Northwestern University and Johns Hopkins University announced they had received about $37 million from the National Heart, Lung and Blood Institute to study a new approach to stroke prevention in patients with atrial fibrillation, an irregular heart rhythm.
The funds will support the Rhythm Evaluation for AntiCoagulaTion (REACT-AF) trial, a seven-year study that will provide...
iRhythm Technologies announced it has received another FDA 510(k) clearance for its ZEUS (Zio ECG Utilization Software) System that works with a wearable to monitor patients with atrial fibrillation, an irregular heart rhythm.
Developed in partnership with Alphabet life science subsidiary Verily, the ZEUS System is a platform that works with the Zio Watch to detect AFib, characterize the amount...
The National Taiwan University Hospital has recently introduced a consumer mobile application that measures heart rhythm to prevent stroke events.
It collaborated with FocalTech Smart Sensors Co., a local human-machine interface technology company, to jointly develop the app called RhythmCam – Heart Rhythm Checker.
WHAT IT DOES
Available for free on iOS and Android devices, the mobile app allows...
New findings from the Apple Heart Study indicate that Apple Watches can identify irregular heartbeats other than atrial fibrillation arrhythmias.
Funded by Apple and conducted by researchers from the Stanford University School of Medicine, the study has been ongoing since 2017. It has enrolled 419,297 Apple Watch and iPhone owners across the U.S. to study the company’s irregular heart rate-...
Apple has made available in Australia its electrocardiogram app for Series 4, 5 and 6 of its Apple Watch. An irregular rhythm notification feature that checks atrial fibrillation was also included in the Apple Watch Series 3 and later versions.
WHAT IT DOES
An Apple Watch with the A-Fib feature uses an optical heart sensor to occasionally check a user's heart rhythm. It alerts the user with a...
AliveCor has updated the capabilities of its mobile ECG devices to identify three additional types of heart conditions, the company announced today.
Sinus rhythm with supraventricular ectopy (SVE), sinus rhythm with premature ventricular contractions (PVCs) and sinus rhythm with wide QRS are now all on the table of AliveCor's KardiaMobile line of ECG devices, which already detected atrial...
Apple has landed a new FDA clearance for an updated version of its ECG feature, allowing the tool to add a category called A-Fib with high heart rate.
This comes a little over two years after Apple first landed a De Novo clearance for its first version of the ECG reading.
The latest version of the ECG feature will be available when the new software update rolls out. This second generation will...
A one-sided arrangement. Earlier this week, budget-minded connected-exercise-maker Echelon Fitness announced the launch of is "Prime Bike," a $499 device that it described in its reveal as "Amazon's first-ever connected fitness product." Through a bring-your-own-tablet interface, the machine would enable owners to join live and on-demand fitness classes through Echelon's subscription service.
"...
